These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25791790)

  • 1. Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.
    Choi GH; Kim GI; Yoo JE; Na DC; Han DH; Roh YH; Park YN; Choi JS
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1444-52. PubMed ID: 25791790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.
    Kim YD; Hwang S; Lee YJ; Kim KH; Ahn CS; Park KM; Moon DB; Ha TY; Song GW; Jung DH; Park SR; Hong HN; Lee SG
    Hepatogastroenterology; 2012; 59(117):1512-5. PubMed ID: 22683968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
    Sheen IS; Jeng KS; Shih SC; Wang PC; Chang WH; Wang HY; Shyung LR; Lin SC; Kao CR; Tsai YC; Wu TY
    World J Gastroenterol; 2004 Jan; 10(1):31-6. PubMed ID: 14695764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma.
    Marubashi S; Nagano H; Wada H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2011 Aug; 18(8):2200-9. PubMed ID: 21301972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
    Jeng KS; Sheen IS; Tsai YC
    Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
    Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
    PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
    Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
    Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
    Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic significance of urinary trypsin inhibitor in patients with hepatocellular carcinoma after hepatectomy.
    Kikuchi I; Uchinami H; Nanjo H; Hashimoto M; Nakajima A; Kume M; Mencin A; Yamamoto Y
    Ann Surg Oncol; 2009 Oct; 16(10):2805-17. PubMed ID: 19636634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
    Morimoto O; Nagano H; Miyamoto A; Fujiwara Y; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
    Surg Today; 2005; 35(12):1033-41. PubMed ID: 16341483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.